Открыть главное меню
Главная
Случайная
Войти
Настройки
О hpluswiki
Отказ от ответственности
hpluswiki
Найти
Редактирование:
NES
Внимание:
Вы не вошли в систему. Ваш IP-адрес будет общедоступен, если вы запишете какие-либо изменения. Если вы
войдёте
или
создадите учётную запись
, её имя будет использоваться вместо IP-адреса, наряду с другими преимуществами.
Анти-спам проверка.
Не
заполняйте это!
Nestin [Nbla00170] ==Publications== {{medline-entry |title=Mini-review: Aging of the neuroendocrine system: Insights from nonhuman primate models. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31891735 |abstract=The neuroendocrine system ([[NES]]) plays a crucial role in synchronizing the physiology and behavior of the whole organism in response to environmental constraints. The [[NES]] consists of a hypothalamic-pituitary-target organ axis that acts in coordination to regulate growth, reproduction, stress and basal metabolism. The growth (or somatotropic), hypothalamic-pituitary-gonadal (HPG), hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-thyroid (HPT) axes are therefore finely tuned by the hypothalamus through the successive release of hypothalamic and pituitary hormones to control the downstream physiological functions. These functions rely on a complex set of mechanisms requiring tight synchronization between peripheral organs and the hypothalamic-pituitary complex, whose functionality can be altered during aging. Here, we review the results of research on the effects of aging on the [[NES]] of nonhuman primate (NHP) species in wild and captive conditions. A focus on the age-related dysregulation of the master circadian pacemaker, which, in turn, alters the synchronization of the [[NES]] with the organism environment, is proposed. Finally, practical and ethical considerations of using NHP models to test the effects of nutrition-based or hormonal treatments to combat the deterioration of the [[NES]] are discussed. |keywords=* Aging * Neuroendocrine system * Nonhuman primate |full-text-url=https://sci-hub.do/10.1016/j.pnpbp.2019.109854 }} {{medline-entry |title=Age Dependent Hypothalamic and Pituitary Responses to Novel Environment Stress or Lipopolysaccharide in Rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29615881 |abstract=Previously, we have shown that the transcription factor nuclear factor interleukin (NF-IL)6 can be used as an activation marker for inflammatory lipopolysaccharide (LPS)-induced and psychological novel environment stress ([[NES]]) in the rat brain. Here, we aimed to investigate age dependent changes of hypothalamic and pituitary responses to [[NES]] (cage switch) or LPS (100 μg/kg) in 2 and 24 months old rats. Animals were sacrificed at specific time points, blood and brains withdrawn and analyzed using immunohistochemistry, RT-PCR and bioassays. In the old rats, telemetric recording revealed that [[NES]]-induced hyperthermia was enhanced and prolonged compared to the young group. Plasma IL-6 levels remained unchanged and hypothalamic IL-6 mRNA expression was increased in the old rats. Interestingly, this response was accompanied by a significant upregulation of corticotropin-releasing hormone mRNA expression only in young rats after [[NES]] and overall higher plasma corticosterone levels in all aged animals. Immunohistochemical analysis revealed a significant upregulation of NF-[[IL6]]-positive cells in the pituitary after [[NES]] or LPS-injection. In another important brain structure implicated in immune-to-brain communication, namely, in the median eminence (ME), NF-[[IL6]]-immunoreactivity was increased in aged animals, while the young group showed just minor activation after LPS-stimulation. Interestingly, we found a higher amount of NF-[[IL6]]-[[CD68]]-positive cells in the posterior pituitary of old rats compared to the young counterparts. Moreover, aging affected the regulation of cytokine interaction in the anterior pituitary lobe. LPS-treatment significantly enhanced the secretion of the cytokines IL-6 and TNFα into supernatants of primary cell cultures of the anterior pituitary. Furthermore, in the young rats, incubation with IL-6 and IL-10 antibodies before LPS-stimulation led to a robust decrease of IL-6 production and an increase of TNFα production by the pituitary cells. In the old rats, this specific cytokine interaction could not be detected. Overall, the present results revealed strong differences in the activation patterns and pathways between old and young rats after both stressors. The prolonged hyperthermic and inflammatory response seen in aged animals seems to be linked to dysregulated pituitary cytokine interactions and brain cell activation (NF-[[IL6]]) in the hypothalamus-pituitary-adrenal axis. |keywords=* NF-IL6 * aging * cage switch * fever * hyperthermia * immune-to-brain communication * lipopolysaccharide * novel environment stress |full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868128 }} {{medline-entry |title=[Prediction of life expectancy for prostate cancer patients based on the kinetic theory of aging of living systems]. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28849878 |abstract=The article presents a methodical approach for prediction of life expectancy for people diagnosed with prostate cancer based on the kinetic theory of aging of living systems. The life expectancy is calculated by solving the differential equation for the rate of aging for three different stage of life - «normal» life, life with prostate cancer and life after combination therapy for prostate cancer. The mathematical model of aging for each stage of life has its own parameters identified by the statistical analysis of healthcare data from the Zharinov's databank and Rosstat CDR [[NES]] databank. The core of the methodical approach is the statistical correlation between growth rate of the prostate specific antigen level (PSA-level) or the PSA doubling time (PSA DT) before therapy, and lifespan: the higher the PSA DT is, the greater lifespan. The patients were grouped under the «fast PSA DT» and «slow PSA DT» categories. The satisfactory matching between calculations and experiment is shown. The prediction error of group life expectancy is due to the completeness and reliability of the main data source. A detailed monitoring of the basic health indicators throughout the each person life in each analyzed group is required. The absence of this particular information makes it impossible to predict the individual life expectancy. |mesh-terms=* Aging * Combined Modality Therapy * Humans * Kinetics * Life Expectancy * Male * Models, Biological * Prostate-Specific Antigen * Prostatic Neoplasms * Reproducibility of Results |keywords=* forecast * kinetic theory of aging of living systems * life expectancy * process speed * prostate cancer * treatment }} {{medline-entry |title=Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. |pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24916776 |abstract=Induced pluripotent stem cells (iPSCs) improve behavior and form neurons after implantation into the stroke-injured adult rodent brain. How the aged brain responds to grafted iPSCs is unknown. We determined survival and differentiation of grafted human fibroblast-derived iPSCs and their ability to improve recovery in aged rats after stroke. Twenty-four months old rats were subjected to 30 min distal middle cerebral artery occlusion causing neocortical damage. After 48 h, animals were transplanted intracortically with human iPSC-derived long-term neuroepithelial-like stem (hiPSC-lt-[[NES]]) cells. Controls were subjected to stroke and were vehicle-injected. Cell-grafted animals performed better than vehicle-injected recipients in cylinder test at 4 and 7 weeks. At 8 weeks, cell proliferation was low (0.7 %) and number of hiPSC-lt-[[NES]] cells corresponded to 49.2% of that of implanted cells. Transplanted cells expressed markers of neuroblasts and mature and GABAergic neurons. Cell-grafted rats exhibited less activated microglia/macrophages in injured cortex and neuronal loss was mitigated. Our study provides the first evidence that grafted human iPSCs survive, differentiate to neurons and ameliorate functional deficits in stroke-injured aged brain. |mesh-terms=* Aging * Analysis of Variance * Animals * Brain Injuries * Cell Differentiation * Disease Models, Animal * ELAV Proteins * Exploratory Behavior * Humans * Induced Pluripotent Stem Cells * Infarction, Middle Cerebral Artery * Ki-67 Antigen * Male * Microtubule-Associated Proteins * Neuropeptides * Phosphopyruvate Hydratase * Rats * Rats, Sprague-Dawley * Recovery of Function * Vascular Endothelial Growth Factor A * gamma-Aminobutyric Acid |keywords=* Stroke * aging * inflammation * neural stem cell * neuroregeneration * recovery * reprogramming * transplantation |full-text-url=https://sci-hub.do/10.3233/RNN-140404 }}
Описание изменений:
Пожалуйста, учтите, что любой ваш вклад в проект «hpluswiki» может быть отредактирован или удалён другими участниками. Если вы не хотите, чтобы кто-либо изменял ваши тексты, не помещайте их сюда.
Вы также подтверждаете, что являетесь автором вносимых дополнений, или скопировали их из источника, допускающего свободное распространение и изменение своего содержимого (см.
Hpluswiki:Авторские права
).
НЕ РАЗМЕЩАЙТЕ БЕЗ РАЗРЕШЕНИЯ ОХРАНЯЕМЫЕ АВТОРСКИМ ПРАВОМ МАТЕРИАЛЫ!
Отменить
Справка по редактированию
(в новом окне)
Шаблон, используемый на этой странице:
Шаблон:Medline-entry
(
править
)